MedPath

mupirocin

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . MUPIROCIN ointment, for topical useInitial U.S. Approval: 1987

Approved
Approval ID

ed60d758-dbce-4963-a378-6c8201c3e66f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 23, 2018

Manufacturers
FDA

Unit Dose Services

DUNS: 831995316

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mupirocin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50436-0112
Application NumberANDA065123
Product Classification
M
Marketing Category
C73584
G
Generic Name
Mupirocin
Product Specifications
Route of AdministrationTOPICAL
Effective DateJanuary 2, 2018
FDA Product Classification

INGREDIENTS (2)

MUPIROCINActive
Quantity: 20 mg in 1 g
Code: D0GX863OA5
Classification: ACTIB
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

mupirocin - FDA Drug Approval Details